Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-22T18:23:34.597Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of repetitive transcranial magnetic stimulation in the treatment of attention-deficit hyperactivity disorser: A case study

Published online by Cambridge University Press:  13 August 2021

E. Asimoglou ,
A. Tsakiri ,
P. Gkikas ,
S. Kalimeris  and
G. Karampoutakis
E. Asimoglou
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
A. Tsakiri*
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
P. Gkikas
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
S. Kalimeris
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
G. Karampoutakis
Affiliation:
Psychiatric And Neurological Center, SMART CNS CENTER, ATHENS, Greece
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Although there are very effective treatment approaches for Attention Deficit Hyperactivity Disorder (ADHD) available, the clinical management has its limits making new treatment modalities a necessity. Evidence suggests that low frequency repetitive transcranial magnetic stimulation (rTMS), improves hyperactivity, impulsivity, and attention deficit of individuals with ADHD.

Objectives

The aim of this case study is to present the effectiveness of rTMS on hyperactivity, impulsivity, and attention deficit of an individual with ADHD.

Methods

This is a case study of a 22 year old male diagnosed with ADHD. The protocol applied was 2 weeks of daily rTMS sessions. This involved repetitive TMS to the right dorsomedial prefrontal cortex (10 Hz, 3.000 pulses, 120% motor threshold) to treat attention deficit, hyperactivity and impulsivity. Assessments were conducted using Adult ADHD Questionnaires, the Jasper and Goldberg questionnaire and WHO self- reported scale at baseline, 1 month and up to 3 months follow up.

Results

The patient showed overall improvement in scores in both ADHD scales with scores dropping more than 50 % in both scales from pre treatment to 3 months follow up. No side effects were recorded during therapy

Conclusions

Our findings suggest that the use of rTMS therapy in individuals with ADHD, is an efficacious and safe therapeutic treatment option.

Keywords

rTMSAttention- Deficit Hyperactivity Disorder
Type
Abstract
Information
European Psychiatry , Volume 64 , Special Issue S1: Abstracts of the 29th European Congress of Psychiatry , April 2021 , pp. S492 - S493
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.